全文获取类型
收费全文 | 2730633篇 |
免费 | 217841篇 |
国内免费 | 4668篇 |
专业分类
耳鼻咽喉 | 39474篇 |
儿科学 | 84969篇 |
妇产科学 | 72423篇 |
基础医学 | 396085篇 |
口腔科学 | 78584篇 |
临床医学 | 247863篇 |
内科学 | 526914篇 |
皮肤病学 | 56517篇 |
神经病学 | 223785篇 |
特种医学 | 108507篇 |
外国民族医学 | 936篇 |
外科学 | 414523篇 |
综合类 | 62205篇 |
现状与发展 | 1篇 |
一般理论 | 1069篇 |
预防医学 | 218975篇 |
眼科学 | 64515篇 |
药学 | 206787篇 |
4篇 | |
中国医学 | 5035篇 |
肿瘤学 | 143971篇 |
出版年
2018年 | 27367篇 |
2016年 | 23245篇 |
2015年 | 26166篇 |
2014年 | 37558篇 |
2013年 | 57238篇 |
2012年 | 77391篇 |
2011年 | 82189篇 |
2010年 | 48282篇 |
2009年 | 46120篇 |
2008年 | 78046篇 |
2007年 | 83190篇 |
2006年 | 84166篇 |
2005年 | 81906篇 |
2004年 | 79074篇 |
2003年 | 76138篇 |
2002年 | 75451篇 |
2001年 | 126877篇 |
2000年 | 131569篇 |
1999年 | 110736篇 |
1998年 | 31462篇 |
1997年 | 28479篇 |
1996年 | 28653篇 |
1995年 | 27505篇 |
1994年 | 25799篇 |
1993年 | 24178篇 |
1992年 | 89437篇 |
1991年 | 87517篇 |
1990年 | 84929篇 |
1989年 | 81995篇 |
1988年 | 76187篇 |
1987年 | 75034篇 |
1986年 | 71102篇 |
1985年 | 67815篇 |
1984年 | 51107篇 |
1983年 | 43617篇 |
1982年 | 26082篇 |
1981年 | 23243篇 |
1980年 | 21858篇 |
1979年 | 48386篇 |
1978年 | 34185篇 |
1977年 | 28702篇 |
1976年 | 27169篇 |
1975年 | 29042篇 |
1974年 | 35805篇 |
1973年 | 33803篇 |
1972年 | 31959篇 |
1971年 | 29700篇 |
1970年 | 27872篇 |
1969年 | 26026篇 |
1968年 | 23828篇 |
排序方式: 共有10000条查询结果,搜索用时 609 毫秒
41.
42.
43.
Samir Gupta MD MDCS AGAF Balambal Bharti MBBS MPH PhD Dennis J. Ahnen MD Daniel D. Buchanan PhD Iona C. Cheng PhD MPH Michelle Cotterchio PhD Jane C. Figueiredo PhD Steven J. Gallinger MD MSc Robert W. Haile DrPH MPH Mark A. Jenkins PhD Noralane M. Lindor MD Finlay A. Macrae MD AGAF Loïc Le Marchand MD PhD Polly A. Newcomb PhD MPH Stephen N. Thibodeau PhD Aung Ko Win MBBS MPH PhD Maria Elena Martinez PhD 《Cancer》2020,126(13):3013-3020
44.
45.
46.
M.F. Werner A. López-Rueda F.X. Zarco J. Blasco L. San Román S. Amaro E. Carrero R. Valero L. Oleaga J.M. Macho N. Bargalló 《Radiologia》2019,61(2):143-152
Purpose
Endovascular treatment with mechanical thrombectomy devices demonstrated high recanalization rates but functional outcome did not correlate with high rates of recanalization obtained. Patient selection prior to the endovascular treatment is very important in the final outcome of the patient. The primary aim of our study was to evaluate the prognostic value of posterior circulation Alberta Stroke Program Early CT Score (pc-ASPECTS) and Pons-Midbrain Index (PMI) scores in patients with Basilar Artery Occlusion (BAO) treated with successful angiographic recanalization after mechanical thrombectomy.Methods
Retrospective single-center study including 18 patients between 2008 and 2013 who had acute basilar artery occlusion managed with endovascular treatment within 24 hours from symptoms onset and with successful angiographic recanalization. The patients were initially classified into two groups according to clinical outcome and mortality at 90 days. For analysis we also divided patients into groups based on pc-ASPECTS (≥8vs.< 8) and PMI (≥3vs.< 3) on non-contrast CT (NCCT) and CT Angiography Source Images (CTASI). Imaging data were correlated to clinical outcome and mortality rate.Results
CTASI pc-ASPECTS, dichotomized at < 8 versus≥8, was associated with a favorable outcome (RR: 2.6; 95% CI: 1.3-5.2) and a reduced risk of death (RR: 6.5: 95% CI: 7.8-23.3). All patients that survived and were functionally independent had pc-ASPECTS score≥8. None of the 5 patients with CTASI pc-ASPECTS score less than 8 survived.Conclusion
PC-ASPECTS on CTASI is helpful for predicting functional outcome after BAO recanalization with endovascular treatment. These results should be validated in a randomized controlled trial in order to decide whether or not to treat a patient with BAO. 相似文献47.
Castro-Kemp Susana Palikara Olympia Gaona Carolina Eirinaki Vasiliki Furlong Michael J. 《School mental health》2020,12(2):284-295
School Mental Health - A dual approach to mental health in schools has been widely defended, where the assessment of psychological distress and the examination of strengths/well-being are two... 相似文献
48.
Die Onkologie - Die Corona-Pandemie hat in den letzten Monaten verdeutlicht, dass das Thema Sterblichkeit trotz erheblicher Fortschritte im Bereich der Hospiz- und Palliativversorgung zu... 相似文献
49.
Michael Staehler Peter J. Goebell Lothar Müller Till-Oliver Emde Natalie Wetzel Lisa Kruggel Martina Jänicke Norbert Marschner the RCC-Registry Group 《International journal of cancer. Journal international du cancer》2020,146(5):1307-1315
Non-clear cell renal cell carcinoma is a very rare malignancy that includes several histological subtypes. Each subtype may need to be addressed separately regarding prognosis and treatment; however, no Phase III clinical trial data exist. Thus, treatment recommendations for patients with non-clear cell metastatic RCC (mRCC) remain unclear. We present first prospective data on choice of first- and second-line treatment in routine practice and outcome of patients with papillary mRCC. From the prospective German clinical cohort study (RCC-Registry), 99 patients with papillary mRCC treated with systemic first-line therapy between December 2007 and May 2017 were included. Prospectively enrolled patients who had started first-line treatment until May 15, 2016, were included into the outcome analyses (n = 82). Treatment was similar to therapies used for clear cell mRCC and consisted of tyrosine kinase inhibitors, mechanistic target of rapamycin inhibitors and recently checkpoint inhibitors. Median progression-free survival from start of first-line treatment was 5.4 months (95% confidence interval [CI], 4.1–9.2) and median overall survival was 12.0 months (95% CI, 8.1–20.0). At data cutoff, 73% of the patients died, 6% were still observed, 12% were lost to follow-up, and 9% were alive at the end of the individual 3-year observation period. Despite the lack of prospective Phase III evidence in patients with papillary mRCC, our real-world data reveal effectiveness of systemic clear cell mRCC therapy in papillary mRCC. The prognosis seems to be inferior for papillary compared to clear cell mRCC. Further studies are needed to identify drivers of effectiveness of systemic therapy for papillary mRCC. 相似文献
50.
Novozhilov A. V. Mindukshev I. V. Korf E. A. Krivchenko A. I. Goncharov N. V. 《Bulletin of experimental biology and medicine》2020,168(4):444-448
Bulletin of Experimental Biology and Medicine - Ammonium, an end-product of catabolism, in low doses can promote adaptation of metabolic pathways in erythrocytes under conditions of extreme... 相似文献